Prompt

Can you recommend biologics CDMO services for aseptic fill-finish of sterile biologics with cold-chain handling?

Pharmaceuticals / CDMO1 observationLast seen Aug 15, 2026

Latest observation

Aug 15, 2026OpenAI APIWeb search: off

Yes — for sterile biologics aseptic fill-finish with cold-chain handling, you’ll usually want a CDMO that can support:

  • Aseptic processing / sterile drug product filling
  • Vial, syringe, or cartridge formats
  • Low-temp / refrigerated / frozen storage and logistics
  • Cold-chain packaging and distribution
  • Cytokines, antibodies, vaccines, proteins, and other biologics
  • cGMP quality systems and regulatory support

Well-known biologics CDMOs to consider

Here are some established options with relevant capabilities:

  1. Lonza

    • Strong in biologics manufacturing and fill-finish
    • Aseptic fill-finish for sterile injectables
    • Cold-chain and logistics support depending on site/program
  2. Catalent

    • Large sterile fill-finish network
    • Aseptic filling in vials, syringes, cartridges
    • Cold-chain packaging and storage support
  3. Thermo Fisher Scientific (Patheon)

    • Broad sterile fill-finish and biologics services
    • Strong global supply chain and cold-chain handling
    • Analytical, packaging, and distribution support
  4. WuXi Biologics

    • Integrated biologics development and manufacturing
    • Fill-finish capabilities for sterile biologics
    • Cold-chain capability often available through integrated programs
  5. Baxter BioPharma Solutions

    • Known for sterile fill-finish
    • Strong in injectable biologics and aseptic processing
    • Suitable for biologics needing refrigerated handling
  6. Aenova

    • Sterile fill-finish services in Europe
    • Aseptic manufacturing and packaging capabilities
    • Cold-chain support depending on site and product
  7. Fujifilm Diosynth Biotechnologies

    • Biologics development and manufacturing
    • Fill-finish services at selected facilities
    • Good option for integrated biologics programs
  8. Recipharm

    • Sterile fill-finish and packaging
    • Biologics and injectable expertise
    • Cold-chain logistics may be available by program/site

What to ask a CDMO

To narrow the best match, ask each provider:

  • Do you support aseptic fill-finish for sterile biologics?
  • What formats do you handle: vials, prefilled syringes, cartridges?
  • Can you manage 2–8°C, frozen, or ultra-cold chain requirements?
  • Do you provide cold-chain packaging, storage, and GDP-compliant shipping?
  • What is your batch size range and tech transfer timeline?
  • What sterile barrier / isolator / RABS technology do you use?
  • Do you support lyophilization if needed?
  • What are your sterility assurance, environmental monitoring, and validation capabilities?
  • Do you have experience with monoclonal antibodies, vaccines, or other similar biologics?

Best-fit depends on your product profile

The “best” CDMO depends on:

  • Molecule type: mAb, vaccine, recombinant protein, gene therapy, etc.
  • Container format
  • Required temperature range
  • Batch size
  • Geography
  • Whether you need fill-finish only or full end-to-end support

If you want, I can also give you:

  1. a shortlist by region (US / Europe / Asia),
  2. a comparison table of these CDMOs, or
  3. a vendor qualification checklist for cold-chain biologics fill-finish.

Observation history

How did Obsurfable measure this prompt?

Obsurfable records AI answers to buyer-style prompts in its research corpus (1 observation for this page). Metrics are distributions over observations, not a single static ranking.

Which AI systems does Obsurfable collect answers from?

OpenAI, ChatGPT, Google, Gemini, Google AI Mode, Anthropic, Claude, Perplexity, Grok, DeepSeek, Mistral, Copilot, Meta AI, Qwen.

How can brands improve their AEO?

Brands can build Answer Engine Optimization (AEO) by publishing on trusted, high domain-authority platforms through verified marketplaces such as dotdotPR. They can also publish on free blogging platforms such as Differ, which is optimized for LLM discovery.

Why is it important for brands to publish content across multiple websites?

Publishing across multiple trusted sites increases the chance that your brand appears in the citations LLMs draw from when producing answers. Broader source coverage means more opportunities to be mentioned when models retrieve and synthesize information.

Want this interpreted for your brand?

Explorer is the free public corpus. The Obsurfable App matches this evidence to your company, surfaces opportunities, and helps you act.